KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Return on Capital Employed (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Return on Capital Employed for 17 consecutive years, with 0.12% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 1.0% to 0.12% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.12% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.12% for FY2025, 1.0% up from the prior year.
  • Return on Capital Employed hit 0.12% in Q4 2025 for Abbott Laboratories, up from 0.11% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.37% in Q4 2022 to a low of 0.1% in Q3 2023.
  • Historically, Return on Capital Employed has averaged 0.17% across 5 years, with a median of 0.12% in 2024.
  • Biggest five-year swings in Return on Capital Employed: grew 8bps in 2021 and later fell -26bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.3% in 2021, then increased by 23bps to 0.37% in 2022, then plummeted by -71bps to 0.11% in 2023, then fell by -3bps to 0.11% in 2024, then rose by 9bps to 0.12% in 2025.
  • Business Quant data shows Return on Capital Employed for ABT at 0.12% in Q4 2025, 0.11% in Q3 2025, and 0.11% in Q2 2025.